Hepatoprotective effect of flavonoid rich fraction of Sesbania grandiflora: Results of In vivo, in vitro, and molecular docking studies

Background: Phytochemicals and their derivatives are promising target drugs for various ailments and have served as therapeutic agents for several decades. Using in vivo and in vitro models and molecular docking, this study investigated the pharmacological potential of a flavonoid-rich fraction of t...

Full description

Saved in:
Bibliographic Details
Main Authors: Anitha Kuttiappan, Santenna Chenchula, Murugesan Vanangamudi, Shvetank Bhatt, Radhika Chikatipalli, P Shaila Bhanu, Nagaraju Bandaru
Format: Article
Language:English
Published: Elsevier 2024-09-01
Series:Journal of Ayurveda and Integrative Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0975947624001517
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846172563122683904
author Anitha Kuttiappan
Santenna Chenchula
Murugesan Vanangamudi
Shvetank Bhatt
Radhika Chikatipalli
P Shaila Bhanu
Nagaraju Bandaru
author_facet Anitha Kuttiappan
Santenna Chenchula
Murugesan Vanangamudi
Shvetank Bhatt
Radhika Chikatipalli
P Shaila Bhanu
Nagaraju Bandaru
author_sort Anitha Kuttiappan
collection DOAJ
description Background: Phytochemicals and their derivatives are promising target drugs for various ailments and have served as therapeutic agents for several decades. Using in vivo and in vitro models and molecular docking, this study investigated the pharmacological potential of a flavonoid-rich fraction of the ethanolic extract of Sesbania grandiflora (SG). Objectives: This research aimed to determine whether flavonoid-rich whole-plant extracts of SGs have any cytoprotective or in vivo hepatoprotective effects. Additionally, the study was intended to elucidate the molecular connections between the discovered flavonoid flavonols and PPARα target proteins linked to liver problems, for which an in silico molecular docking investigation was performed. Materials and methods: To separate the flavonoid components, the entire Sesbania grandiflora plant was first extracted using ethanol as a solvent by soxhlet extraction. The resulting ethanolic extract was then fractionated. The cytoprotective and hepatoprotective properties were evaluated via in vitro and in vivo experiments. SGOT, SGPT, triglyceride, bilirubin, and total protein levels were used to evaluate hepatotoxicity in animal models. In vitro studies on Hepatocellular Carcinoma G2 (HepG2) cell lines have examined their cytotoxic effects and antioxidant activity. The most promising flavonoid-flavanol compounds were identified by conducting molecular docking studies against PPARα target protein (PDB ID: 3VI8) using MOE software. Results: In vivo, the serum levels of SGOT, SGPT, total triglyceride and total bilirubin were measured in experimental animals treated with the flavonoid-rich ethanolic extract of SG. Significant reductions in the levels of these hepatic injury markers were observed, indicating the hepatoprotective potential of the extract. Elevated levels of liver biomarkers in the untreated group indicated liver injury or dysfunction. The treated groups showed significant restoration of these biomarkers, suggesting the hepatoprotective potential of SG. The IC50 value for the total flavonoid content of SG was 190.28 μg/ml, indicating its safety in inhibiting HepG2 cell growth. Flavonoid treatment decreased cell viability but did not affect antioxidant parameters in hepatocytes. In addition, SG restored the damaged hepatocyte architecture. Molecular docking studies revealed the binding affinities of flavonoids for PPARα. These findings suggest that a promising lead candidate for the development of therapeutic medicines against anti-TB drug-induced hepatotoxicity has been identified. Conclusion: Our findings demonstrate the hepatoprotective potential of the flavonoid-rich fraction of Sesbania grandiflora both in vivo and in vitro. This study provides valuable insights into its mechanism of action, highlighting its promising therapeutic application in the management of liver disorders. This study highlights the hepatoprotective and cytoprotective potential of the total flavonoid-rich fraction of SG.
format Article
id doaj-art-f85d8fb89c6b410abed876eb4e6a9ad6
institution Kabale University
issn 0975-9476
language English
publishDate 2024-09-01
publisher Elsevier
record_format Article
series Journal of Ayurveda and Integrative Medicine
spelling doaj-art-f85d8fb89c6b410abed876eb4e6a9ad62024-11-10T04:07:44ZengElsevierJournal of Ayurveda and Integrative Medicine0975-94762024-09-01155101036Hepatoprotective effect of flavonoid rich fraction of Sesbania grandiflora: Results of In vivo, in vitro, and molecular docking studiesAnitha Kuttiappan0Santenna Chenchula1Murugesan Vanangamudi2Shvetank Bhatt3Radhika Chikatipalli4P Shaila Bhanu5Nagaraju Bandaru6Department of Pharmacology, School of Pharmacy and Technology Management (SPTM), SVKM's Narsee Monjee Institute of Management Studies (NMIMS) Deemed-to-University, Shirpur 425405, Maharashtra, IndiaDepartment of Pharmacology, All India Institute of Medical Sciences (AIIMS), Bhopal 462020, Madhya Pradesh, India; Corresponding author. Department of Pharmacology, AIIMS Bhopal, Madhya Pradesh, 462020, India.Amity Institute of Pharmacy, Amity University Madhya Pradesh, Gwalior, Madhya Pradesh, 474005, IndiaSchool of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Pune 411038, Maharashtra, IndiaSri Venkateswara College of Pharmacy, Chittoor 517120, Andhra Pradesh, IndiaSree Vidyanikethan College of Pharmacy, Sree Sainath Nagar, Tirupathi 517102, Andhra Pradesh, IndiaDepartment of Pharmacology, School of Pharmaceutical Sciences (SOPS), Sandip University, Nasik 422213, Maharashtra, IndiaBackground: Phytochemicals and their derivatives are promising target drugs for various ailments and have served as therapeutic agents for several decades. Using in vivo and in vitro models and molecular docking, this study investigated the pharmacological potential of a flavonoid-rich fraction of the ethanolic extract of Sesbania grandiflora (SG). Objectives: This research aimed to determine whether flavonoid-rich whole-plant extracts of SGs have any cytoprotective or in vivo hepatoprotective effects. Additionally, the study was intended to elucidate the molecular connections between the discovered flavonoid flavonols and PPARα target proteins linked to liver problems, for which an in silico molecular docking investigation was performed. Materials and methods: To separate the flavonoid components, the entire Sesbania grandiflora plant was first extracted using ethanol as a solvent by soxhlet extraction. The resulting ethanolic extract was then fractionated. The cytoprotective and hepatoprotective properties were evaluated via in vitro and in vivo experiments. SGOT, SGPT, triglyceride, bilirubin, and total protein levels were used to evaluate hepatotoxicity in animal models. In vitro studies on Hepatocellular Carcinoma G2 (HepG2) cell lines have examined their cytotoxic effects and antioxidant activity. The most promising flavonoid-flavanol compounds were identified by conducting molecular docking studies against PPARα target protein (PDB ID: 3VI8) using MOE software. Results: In vivo, the serum levels of SGOT, SGPT, total triglyceride and total bilirubin were measured in experimental animals treated with the flavonoid-rich ethanolic extract of SG. Significant reductions in the levels of these hepatic injury markers were observed, indicating the hepatoprotective potential of the extract. Elevated levels of liver biomarkers in the untreated group indicated liver injury or dysfunction. The treated groups showed significant restoration of these biomarkers, suggesting the hepatoprotective potential of SG. The IC50 value for the total flavonoid content of SG was 190.28 μg/ml, indicating its safety in inhibiting HepG2 cell growth. Flavonoid treatment decreased cell viability but did not affect antioxidant parameters in hepatocytes. In addition, SG restored the damaged hepatocyte architecture. Molecular docking studies revealed the binding affinities of flavonoids for PPARα. These findings suggest that a promising lead candidate for the development of therapeutic medicines against anti-TB drug-induced hepatotoxicity has been identified. Conclusion: Our findings demonstrate the hepatoprotective potential of the flavonoid-rich fraction of Sesbania grandiflora both in vivo and in vitro. This study provides valuable insights into its mechanism of action, highlighting its promising therapeutic application in the management of liver disorders. This study highlights the hepatoprotective and cytoprotective potential of the total flavonoid-rich fraction of SG.http://www.sciencedirect.com/science/article/pii/S0975947624001517Sesbania grandifloraFlavonoidsHepG2 cellsMTT assayHepatotoxicity
spellingShingle Anitha Kuttiappan
Santenna Chenchula
Murugesan Vanangamudi
Shvetank Bhatt
Radhika Chikatipalli
P Shaila Bhanu
Nagaraju Bandaru
Hepatoprotective effect of flavonoid rich fraction of Sesbania grandiflora: Results of In vivo, in vitro, and molecular docking studies
Journal of Ayurveda and Integrative Medicine
Sesbania grandiflora
Flavonoids
HepG2 cells
MTT assay
Hepatotoxicity
title Hepatoprotective effect of flavonoid rich fraction of Sesbania grandiflora: Results of In vivo, in vitro, and molecular docking studies
title_full Hepatoprotective effect of flavonoid rich fraction of Sesbania grandiflora: Results of In vivo, in vitro, and molecular docking studies
title_fullStr Hepatoprotective effect of flavonoid rich fraction of Sesbania grandiflora: Results of In vivo, in vitro, and molecular docking studies
title_full_unstemmed Hepatoprotective effect of flavonoid rich fraction of Sesbania grandiflora: Results of In vivo, in vitro, and molecular docking studies
title_short Hepatoprotective effect of flavonoid rich fraction of Sesbania grandiflora: Results of In vivo, in vitro, and molecular docking studies
title_sort hepatoprotective effect of flavonoid rich fraction of sesbania grandiflora results of in vivo in vitro and molecular docking studies
topic Sesbania grandiflora
Flavonoids
HepG2 cells
MTT assay
Hepatotoxicity
url http://www.sciencedirect.com/science/article/pii/S0975947624001517
work_keys_str_mv AT anithakuttiappan hepatoprotectiveeffectofflavonoidrichfractionofsesbaniagrandifloraresultsofinvivoinvitroandmoleculardockingstudies
AT santennachenchula hepatoprotectiveeffectofflavonoidrichfractionofsesbaniagrandifloraresultsofinvivoinvitroandmoleculardockingstudies
AT murugesanvanangamudi hepatoprotectiveeffectofflavonoidrichfractionofsesbaniagrandifloraresultsofinvivoinvitroandmoleculardockingstudies
AT shvetankbhatt hepatoprotectiveeffectofflavonoidrichfractionofsesbaniagrandifloraresultsofinvivoinvitroandmoleculardockingstudies
AT radhikachikatipalli hepatoprotectiveeffectofflavonoidrichfractionofsesbaniagrandifloraresultsofinvivoinvitroandmoleculardockingstudies
AT pshailabhanu hepatoprotectiveeffectofflavonoidrichfractionofsesbaniagrandifloraresultsofinvivoinvitroandmoleculardockingstudies
AT nagarajubandaru hepatoprotectiveeffectofflavonoidrichfractionofsesbaniagrandifloraresultsofinvivoinvitroandmoleculardockingstudies